Alpha Paradigm Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
BCM
EC
BG
Alpha Paradigm Partners's TNDM Position: Q3 2022 in Review
Alpha Paradigm Partners sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 14,157 shares — an estimated $838K sold.
Alpha Paradigm Partners first reported a position in TNDM in Q1 2022 and held it in 2 quarters. The position peaked at $838K in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.
- Alpha Paradigm Partners reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
- Alpha Paradigm Partners sold 14,157 Tandem Diabetes Care shares in Q3 2022, an estimated $838K.
- Alpha Paradigm Partners first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 2 quarters.
- Alpha Paradigm Partners's Tandem Diabetes Care position peaked at $838K in Q2 2022.
- 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.
Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.